Since trAbs not only mediate direct tumor cell killing, but also elicit a vaccination effect [17], we then asked whether the immunologic memory induced by trAbs is affected by the combination with anti-CTLA-4 treatment. The gene discussed is CTLA4; the disease is neoplasm.